Erythropoietin Stimulating Agents Market is estimated to grow at a CAGR of about 8.3% during the forecast period| Key Vendors - 3SBIO INC., JOHNSON & JOHNSON, BIOSIDUS, BIOCON, HOSPIRA, CELLTRION, amongst others

Market Analysis:

Asia-Pacific is expected to grow at the Highest CAGR
Asia-Pacific region is expected to grow at the highest CAGR, during the forecast period. Because of the emerging economies and new product launches with better efficacy. North America region holds the largest market share, followed by Europe, in the forecast period.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16808
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Erythropoietin stimulating agents are the drugs which are similar to erythropoietin. This agent stimulates the growth of red blood cells (RBC). Erythropoietin-stimulating agents are approved for the treatment of anemia due to chronic kidney failure (CKD), chemotherapy, HIV, and also for the reduced RBC during critical surgical procedures. Over the past decade, anemia has emerged as one of the serious diseases related to nutrition, accompanied by increased morbidity and mortality. . And even the chronic infections, including tuberculosis, malaria, HIV, and cancer can also lower blood Hb concentrations. All the above factors, like increased mortality, iron deficiency, and insufficient RBC production, are the major factors driving the erythropoietin stimulating agents market. The other factors, like increasing applications in HIV, end-stage renal disorder, and the risks of thrombosis during surgery and pure red cell aplasia, are driving the market.

Request Discount on this report @ https://marketprognosis.com/discount-request/16808
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments:
Erythropoietin Stimulating Agents Market is segmented by:
1. Type: Epoetin – Alfa, Epoetin – Beta, Epoetin – Omega, Epoetin – Delta, Darbepoetin – Alpha, Others
2. Application: Cancer Chemotherapy, Renal Disorders, Anti-retroviral treatment, Neural diseases, Others
3. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• June 2017: Johnson & Johnson completed the acquisition of Actelion.
• January 2017: Amgen made an agreement with DaVita, for new sourcing and supply.

Enquiry before Buying @ https://marketprognosis.com/enquiry/16808
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today's complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.